Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.
This suit contends that Nexium was not an attempt to provide an improved drug, but a money-making ploy to market a drug remarkably similar to Prilosec and soften the substantial financial losses they were sure to incur with the expiration of the Prilosec patent and increased competition from generic drugs.
